"We were one of the first CPT® Plasma.Competence.Centers in Germany. Cold plasma therapy has opened up new business areas for us."
"We were one of the first CPT® Plasma.Competence.Centers in Germany. Cold plasma therapy has opened up new business areas for us."
By loading the video, you accept YouTube's privacy policy.
Learn more
Because it's about improving the quality of wound care and not just treating wounds, but healing them sustainably.
The CPT® Plasma.Competence.Centers are specialized treatment centers with the highest hygienic standards and holistic approach where patients with chronic and difficult-to-heal wounds are treated professionally.
We have set ourselves the goal of ensuring significantly improved specialized wound treatment for patients with chronic and/or difficult-to-heal wounds compared to the previous standard care.
Our approach: quality and innovative treatment methods in wound management
Close-meshed internal and external quality assurance is continuously documented and carried out in our centers. On average, specialized audits and QM audits are carried out twice a year and are thus recorded.
The aim of this system standard is to standardize and define a minimum standard for organizational systems of our treatment facilities
It is important to us that our philosophy, the necessary quality standards and also the treatment criteria are adhered to and lived. Therefore, we carry out an audit with all applicants,
during which we check whether the necessary criteria are met in the following subject areas:
For treatment, a CPT®patch is to be applied to the wound area and operated by means of the CPT®cube.
For treatment, a CPT®patch is to be applied to the wound area and operated by means of the CPT®cube.
After a successful pilot phase, we officially appoint the new partner as CPT® Plasma.Competence.Center. From then on, a comprehensive support package will also be available:
Plasma consultation hour
Technical on-site support by arrangement
Online treatment support
Technical equipment
48 hours cube exchange service
Telephone hotline for technical support
Support in billing issues
Integration into all central marketing measures (analog/digital)
Right to use the brand logos
Networking with the Coldplasmatech website and Info Hub
Involvement in press work/support for regional press work
Information and use of presence at trade fairs and congresses
Newsletter
Support for prescriber events (presence, hybrid, online)
Use of the specialist network plasma medicine
Social media integration (Facebook, Instagram, LinkedIn, Twitter, TikTok, etc.)
The Federal Joint Committee has recognized the relevance of cold plasma therapy and confirmed this by initiating a trial study. However, the classification of the CPT®patch in the SHI benefits catalog has not yet been conclusively clarified.
It is conceivable that the CPT®patch can be classified as a dressing and can therefore be dispensed without further ado in accordance with the known principles of the economic efficiency requirement.
However, it is also conceivable that it is to be classified as another wound care product or as part of a new method and can therefore currently only be dispensed if approved by the health insurance company.
In this situation, it is advisable to have the health insurance company expressly confirm in writing that it recognizes its obligation to provide benefits in advance of dispensing the CPT®patch in order to protect against retaxation.
For the confirmation of the obligation to pay benefits to be declared to the insured person, it makes sense for the treating physician to explain the individual severity of the illness and, above all, the unsuccessful exhaustion of all more cost-effective alternatives and the available evidence.
The Federal Joint Committee has recognized the relevance of cold plasma therapy and confirmed this by initiating a trial study. However, the classification of the CPT®patch in the SHI benefits catalog has not yet been conclusively clarified.
It is conceivable that the CPT®patch can be classified as a dressing and can therefore be dispensed without further ado in accordance with the known principles of the economic efficiency requirement.
However, it is also conceivable that it is to be classified as another wound care product or as part of a new method and can therefore currently only be dispensed if approved by the health insurance company.
In this situation, it is advisable to have the health insurance company expressly confirm in writing that it recognizes its obligation to provide benefits in advance of dispensing the CPT®patch in order to protect against retaxation.
For the confirmation of the obligation to pay benefits to be declared to the insured person, it makes sense for the treating physician to explain the individual severity of the illness and, above all, the unsuccessful exhaustion of all more cost-effective alternatives and the available evidence.
